Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2023 07:58 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

Entered into a collaboration with Tempus giving Recursion access to over 20 petabytes of multimodal oncology data for the purpose of training causal AI models together with Recursion’s proprietary...
November 02, 2023 08:05 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conference

SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
September 05, 2023 16:30 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
September 05, 2023 07:59 ET | Source: Recursion Pharmaceuticals

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has...
August 08, 2023 08:00 ET | Source: Recursion Pharmaceuticals

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has...
August 08, 2023 07:58 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein interactions for approximately 36 billion compounds in the Enamine REAL Space, reported to be the world’s...
August 01, 2023 08:30 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conference

SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
July 26, 2023 18:58 ET | Source: Recursion Pharmaceuticals

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today launched Valence Labs at...
July 13, 2023 02:51 ET | Source: Recursion Pharmaceuticals

Recursion ने AI-सक्षम औषधि खोज में अभूतपूर्व फाउंडेशन मॉडल में तेज़ी लाने के लिए NVIDIA से सहयोग और $50 मिलियन के निवेश की घोषणा की

साल्ट लेक सिटी, टोरंटो और मॉन्ट्रियल, July 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), औषधि खोज को औद्योगिक बनानेवाली एक अग्रणी क्लिनिकल स्टेज TechBio कंपनी ने, आज NVIDIA द्वारा $50...
July 13, 2023 02:51 ET | Source: Recursion Pharmaceuticals

Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an

SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), ein führendes, im klinischen Stadium tätiges TechBio-Unternehmen, das die Biologie dekodiert,...